Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial

por Walter, I., Schulz, U., Vogelhuber, M., Wiedmann, K., Endlicher, E., Klebl, F., Andreesen, R., Herr, W., Ghibelli, L., Hackl, C., Wiest, R., Reichle, A.
Publicado 2017

Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

por Winkler, M, Pratschke, J, Schulz, U, Zheng, S, Zhang, M, Li, W, Lu, M, Sgarabotto, D, Sganga, G, Kaskel, P, Chandwani, S, Ma, L, Petrovic, J, Shivaprakash, M
Publicado 2010